Unitedhealth Group Inc. (UNH)

NYSE:UNH

UNH

UnitedHealth

RESEARCH TOOLSreports

UnitedHealth (UNH) Stock Forecast & Price Target

23,570 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

UNH Analyst Ratings

Strong Buy

18 Buy

4 Hold

0 Sell

Based on 22 analysts giving stock ratings to

UnitedHealth

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

UNH Stock 12 Month Forecast

Average Price Target

$368.15

▲(34.37% Upside)

Based on 22 Wall Street analysts offering 12 month price targets for UnitedHealth in the last 3 months. The average price target is $368.15 with a high forecast of $440.00 and a low forecast of $311.00. The average price target represents a 34.37% change from the last price of $273.98.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"231":"$231","370":"$370","509":"$509","300.5":"$300.5","439.5":"$439.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":440,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$440.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":368.15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$368.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":311,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$311.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[231,300.5,370,439.5,509],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,273.98,286.75076923076927,299.52153846153846,312.2923076923077,325.06307692307695,337.83384615384614,350.6046153846154,363.37538461538463,376.1461538461539,388.91692307692307,401.6876923076923,414.4584615384615,427.22923076923075,{"y":440,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,273.98,281.2238461538462,288.46769230769235,295.71153846153845,302.9553846153846,310.1992307692308,317.44307692307694,324.68692307692305,331.9307692307692,339.1746153846154,346.41846153846154,353.66230769230765,360.9061538461538,{"y":368.15,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,273.98,276.8276923076923,279.67538461538464,282.5230769230769,285.37076923076927,288.21846153846155,291.06615384615384,293.9138461538462,296.76153846153846,299.60923076923075,302.4569230769231,305.3046153846154,308.1523076923077,{"y":311,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":508.773,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":389.691,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 64,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":296.363,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 72,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":319.447,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 62,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":232.89,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":303.511,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 57,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":343.304,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 70,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":336.661,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":318.574,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.563,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":283.386,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":292.654,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":273.98,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$440.00

Average Price Target$368.15

Lowest Price Target$311.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Scott Fidel

Goldman Sachs

$400

Buy

46.00%

Upside

Reiterated

04/02/26

Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), IDEAYA Biosciences (NASDAQ: IDYA) and Bristol-Myers Squibb (NYSE: BMY)

Hans Engel

Erste Group

―

Hold

―

Reiterated

04/02/26

UnitedHealth (UNH) Receives a Hold from Erste Group

John Ransom

Raymond James

$330

Buy

20.45%

Upside

Upgraded

04/01/26

UnitedHealth upgraded to Outperform from Market Perform at Raymond JamesUnitedHealth upgraded to Outperform from Market Perform at Raymond James

Lance Wilkes

Bernstein

$405

Buy

47.82%

Upside

Reiterated

03/30/26

Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (NASDAQ: CNTA), UnitedHealth (NYSE: UNH) and Adagio Medical Holdings (NASDAQ: ADGM)

David Windley

Jefferies

$340

Buy

24.10%

Upside

Reiterated

02/27/26

Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (NASDAQ: DFTX), Structure Therapeutics, Inc. Sponsored ADR (NASDAQ: GPCR) and UnitedHealth (NYSE: UNH)

George Hill

Deutsche Bank

―

Hold

―

Reiterated

02/20/26

Analysts Offer Insights on Healthcare Companies: Butterfly Network (NYSE: BFLY), UnitedHealth (NYSE: UNH) and Travere Therapeutics (NASDAQ: TVTX)

Ann Hynes

Mizuho Securities

$430→$350

Buy

27.75%

Upside

Reiterated

02/05/26

UnitedHealth price target lowered to $350 from $430 at MizuhoUnitedHealth price target lowered to $350 from $430 at Mizuho

Jessica Tassan

Piper Sandler

$396→$390

Buy

42.35%

Upside

Reiterated

02/03/26

Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), UnitedHealth (NYSE: UNH) and Johnson & Johnson (NYSE: JNJ)

David S Macdonald

Truist Financial

$410→$370

Buy

35.05%

Upside

Reiterated

02/02/26

Analysts Conflicted on These Healthcare Names: UnitedHealth (NYSE: UNH), CytomX Therapeutics (NASDAQ: CTMX) and Beta Bionics, Inc. (NASDAQ: BBNX)

Bram Kaplan

J.P. Morgan

$425→$389

Buy

41.98%

Upside

Reiterated

02/02/26

UnitedHealth price target lowered to $389 from $425 at JPMorganUnitedHealth price target lowered to $389 from $425 at JPMorgan

Stephen Baxter

Wells Fargo

$400→$370

Buy

35.05%

Upside

Reiterated

01/30/26

UnitedHealth price target lowered to $370 from $400 at Wells FargoUnitedHealth price target lowered to $370 from $400 at Wells Fargo

Andrew Mok CFA

Barclays

$391→$327

Buy

19.35%

Upside

Reiterated

01/29/26

Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), Cytokinetics (NASDAQ: CYTK) and Moderna (NASDAQ: MRNA)

Ryan Langston

TD Cowen

$338→$311

Hold

13.51%

Upside

Reiterated

01/29/26

Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV) and UnitedHealth (NYSE: UNH)

Erin Wright

Morgan Stanley

$409→$375

Buy

36.87%

Upside

Reiterated

01/28/26

UnitedHealth: Buy Rating Reaffirmed on Resilient Earnings, Margin Discipline, and Long-Term Growth Despite Medicare Policy Headwinds

Michael Wiederhorn

Oppenheimer

$415→$385

Buy

40.52%

Upside

Reiterated

01/28/26

UnitedHealth price target lowered to $385 from $415 at OppenheimerUnitedHealth price target lowered to $385 from $415 at Oppenheimer

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Scott Fidel

Goldman Sachs

$400

Buy

46.00%

Upside

Reiterated

04/02/26

Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), IDEAYA Biosciences (NASDAQ: IDYA) and Bristol-Myers Squibb (NYSE: BMY)

Hans Engel

Erste Group

―

Hold

―

Reiterated

04/02/26

UnitedHealth (UNH) Receives a Hold from Erste Group

John Ransom

Raymond James

$330

Buy

20.45%

Upside

Upgraded

04/01/26

UnitedHealth upgraded to Outperform from Market Perform at Raymond JamesUnitedHealth upgraded to Outperform from Market Perform at Raymond James

Lance Wilkes

Bernstein

$405

Buy

47.82%

Upside

Reiterated

03/30/26

Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (NASDAQ: CNTA), UnitedHealth (NYSE: UNH) and Adagio Medical Holdings (NASDAQ: ADGM)

David Windley

Jefferies

$340

Buy

24.10%

Upside

Reiterated

02/27/26

Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (NASDAQ: DFTX), Structure Therapeutics, Inc. Sponsored ADR (NASDAQ: GPCR) and UnitedHealth (NYSE: UNH)

George Hill

Deutsche Bank

―

Hold

―

Reiterated

02/20/26

Analysts Offer Insights on Healthcare Companies: Butterfly Network (NYSE: BFLY), UnitedHealth (NYSE: UNH) and Travere Therapeutics (NASDAQ: TVTX)

Ann Hynes

Mizuho Securities

$430→$350

Buy

27.75%

Upside

Reiterated

02/05/26

UnitedHealth price target lowered to $350 from $430 at MizuhoUnitedHealth price target lowered to $350 from $430 at Mizuho

Jessica Tassan

Piper Sandler

$396→$390

Buy

42.35%

Upside

Reiterated

02/03/26

Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), UnitedHealth (NYSE: UNH) and Johnson & Johnson (NYSE: JNJ)

David S Macdonald

Truist Financial

$410→$370

Buy

35.05%

Upside

Reiterated

02/02/26

Analysts Conflicted on These Healthcare Names: UnitedHealth (NYSE: UNH), CytomX Therapeutics (NASDAQ: CTMX) and Beta Bionics, Inc. (NASDAQ: BBNX)

Bram Kaplan

J.P. Morgan

$425→$389

Buy

41.98%

Upside

Reiterated

02/02/26

UnitedHealth price target lowered to $389 from $425 at JPMorganUnitedHealth price target lowered to $389 from $425 at JPMorgan

Stephen Baxter

Wells Fargo

$400→$370

Buy

35.05%

Upside

Reiterated

01/30/26

UnitedHealth price target lowered to $370 from $400 at Wells FargoUnitedHealth price target lowered to $370 from $400 at Wells Fargo

Andrew Mok CFA

Barclays

$391→$327

Buy

19.35%

Upside

Reiterated

01/29/26

Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH), Cytokinetics (NASDAQ: CYTK) and Moderna (NASDAQ: MRNA)

Ryan Langston

TD Cowen

$338→$311

Hold

13.51%

Upside

Reiterated

01/29/26

Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV) and UnitedHealth (NYSE: UNH)

Erin Wright

Morgan Stanley

$409→$375

Buy

36.87%

Upside

Reiterated

01/28/26

UnitedHealth: Buy Rating Reaffirmed on Resilient Earnings, Margin Discipline, and Long-Term Growth Despite Medicare Policy Headwinds

Michael Wiederhorn

Oppenheimer

$415→$385

Buy

40.52%

Upside

Reiterated

01/28/26

UnitedHealth price target lowered to $385 from $415 at OppenheimerUnitedHealth price target lowered to $385 from $415 at Oppenheimer

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering UnitedHealth

3 Months

xxx

Success Rate

29/45 ratings generated profit

Average Return

+5.35%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 64.44% of your transactions generating a profit, with an average return of +5.35% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

35/43 ratings generated profit

Average Return

+20.36%

reiterated a buy rating 5 days ago

Copying Scott Fidel's trades and holding each position for 1 Year would result in 81.40% of your transactions generating a profit, with an average return of +20.36% per trade.

2 Years

xxx

Success Rate

37/45 ratings generated profit

Average Return

+39.96%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 82.22% of your transactions generating a profit, with an average return of +39.96% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UNH Analyst Recommendation Trends

Rating

Dec 25

Jan 26

Feb 26

Mar 26

Apr 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, UNH has received 9 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. UNH average Analyst price target in the past 3 months is 368.15.

Each month's total comprises the sum of three months' worth of ratings.

UNH Financial Forecast

UNH Earnings Forecast

Next quarter’s earnings estimate for UNH is $6.65 with a range of $5.01 to $7.36. The previous quarter’s EPS was $2.11. UNH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year UNH has Performed in-line its overall industry.

UNH Sales Forecast

Next quarter’s sales forecast for UNH is $109.58B with a range of $106.85B to $114.00B. The previous quarter’s sales results were $113.22B. UNH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year UNH has Performed in-line its overall industry.

UNH Stock Forecast FAQ

What is UNH’s average 12-month price target, according to analysts?

Based on analyst ratings, Unitedhealth Group Inc.’s 12-month average price target is 368.15.

What is UNH’s upside potential, based on the analysts’ average price target?

Unitedhealth Group Inc. has 34.37% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is UNH a Buy, Sell or Hold?

Unitedhealth Group Inc. has a consensus rating of Strong Buy which is based on 18 buy ratings, 4 hold ratings and 0 sell ratings.

What is Unitedhealth Group Inc.’s price target?

The average price target for Unitedhealth Group Inc. is 368.15. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $440.00 ,the lowest forecast is $311.00. The average price target represents 34.37% Increase from the current price of $273.98.

What do analysts say about Unitedhealth Group Inc.?

Unitedhealth Group Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 22 Wall Streets Analysts.

How can I buy shares of UNH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

UnitedHealth (UNH) Stock Forecast & Price Target

UNH Analyst Ratings

UNH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering UnitedHealth

UNH Analyst Recommendation Trends

UNH Financial Forecast

UNH Earnings Forecast

UNH Sales Forecast

UNH Stock Forecast FAQ

Detailed List of Analyst Forecasts